TGA Provisional Approval of Roche Products Pty Ltd COVID-19 treatment, casirivimab + ...

Retrieved on: 2021-10-17 22:09:08

Tags for this article:

Coronaviridae

Viruses

Medical specialties

Antiviral drugs

COVID-19 drug development

Monoclonal antibodies

Zoonoses

Sarbecovirus

Casirivimab/imdevimab

Coronavirus spike protein

COVID-19

Severe acute respiratory syndrome coronavirus 2

Roche Products Pty Ltd

Click the tags to see associated articles and topics

TGA Provisional Approval of Roche Products Pty Ltd COVID-19 treatment, casirivimab + .... View article details on HISWAI: https://www.tga.gov.au/media-release/tga-provisional-approval-roche-products-pty-ltd-covid-19-treatment-casirivimab-imdevimab-ronapreve

Excerpt

The TGA has provisionally approved the use of the Roche Products Pty Ltd combination therapy, casirivimab + imdevimab (RONAPREVE), for the treatment and ...

Article found on: www.tga.gov.au

View Original Article